Tenax Therapeutics, Inc. (TENX)

NASDAQ

$1.71

$-0.01

(-0.52%)

Pre-Market

Tenax Therapeutics, Inc. (TENX) Live Price Chart

Last updated: ⁦2026-10-22 12:01:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Tenax Therapeutics, Inc. (TENX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.71, with a market capitalization of $61.00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $19.40. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$61.00M
Open	$1.72
Day's High	$152,320.00
Day's Low	$1.31
Previous Close	$1.63
Volume	43.74K
Average Volume	5.73M
P/E Ratio	--
52-Week High	$19.40
52-Week Low	$1.31
Dividend Yield	--
Earnings Date	--

Tenax Therapeutics, Inc. (TENX) Pre-Market Stock Price

Tenax Therapeutics, Inc. (TENX) is trading at $1.71 in pre-market trading as of 2026-10-22 11:59:00, up 4.79% ($0.08) from the previous close of $1.63

Pre-market trading shows how investors are pricing TENX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Tenax Therapeutics, Inc. (TENX) 7-Day Stock Price Change

Over the past seven days, Tenax Therapeutics, Inc. (TENX) moved from $1.60 to $1.71, representing a gain of 6.75% ($0.11).

The stock traded between $1.36 and $1.84 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 2.84 million shares, up versus the previous seven-day period, indicating higher trading activity.

TENX 52-Week Price Position

Position in Range: 2.2%

52W Low$1.31

52W High$19.40

TENX is currently trading at $1.71, placing it 2.2% of the way from its 52-week low of $1.31 to its 52-week high of $19.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Tenax Therapeutics, Inc. (TENX)?

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Tenax Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	16
Exchange	NASDAQ
Company Website	https://www.tenaxthera.com

How to Buy Tenax Therapeutics, Inc. (TENX) Stock on MEXC

Eligible investors can buy real shares of Tenax Therapeutics, Inc. (TENX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TENX and Place Your Order

Open the RealStocks trading page and search for TENX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Tenax Therapeutics, Inc. (TENX) stock price today?

Tenax Therapeutics, Inc. (TENX) is currently trading at $ 1.71, up 4.79% ($0.08) from the previous close of $ 1.63. Intraday prices update in real time during regular trading hours.

2.Is TENX stock going up or down today?

As of 2026-10-22 11:59:00, TENX is trading at $ 1.71, up 4.79% ($0.08) from its previous close of $ 1.63. The stock has traded between $ 1.31 and $ 152,320.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is TENX pre-market price?

As of 2026-10-22 11:59:00, TENX is trading at $ 1.71 in pre-market trading, up 4.79% ($0.08) from the previous close of $ 1.63. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TENX after-hours price?

As of 2026-10-22 11:59:00, TENX is trading at $ 1.72 in after-hours trading, up 5.46% ($0.09) from the regular-session close of $ 1.63. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TENX stock trading now?

TENX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TENX sit relative to its 52-week high and low?

Over the past 52 weeks, TENX has traded between a low of $ 1.31 and a high of $ 19.40. At $ 1.71, the stock is positioned 2.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Tenax Therapeutics, Inc. in?

Tenax Therapeutics, Inc. (TENX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Tenax Therapeutics, Inc.'s market capitalization and where is it listed?

Tenax Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 61.00M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TENX valued in terms of P/E ratio and EPS?

TENX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.73. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Tenax Therapeutics, Inc. pay a dividend?

Tenax Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.